Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1989 Sep;60(3):366–369. doi: 10.1038/bjc.1989.286

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.

J W Sweetenham 1, G M Mead 1, D H Wright 1, J J McKendrick 1, D H Jones 1, C J Williams 1, J M Whitehouse 1
PMCID: PMC2247183  PMID: 2789943

Abstract

Between January 1977 and January 1988, 19 patients with non-Hodgkin's lymphoma (NHL) involving the ileocaecal region were cared for by the CRC Wessex Medical Oncology Unit. Fifteen of these patients had primary ileocaecal NHL (stages IE or IIE) and four had secondary involvement of this region (stage IV). The commonest clinical presentation was with abdominal pain and a palpable mass in the right iliac fossa. Bulky (greater than 10 cm) disease was a particularly common feature, and complete surgical removal was possible in only seven patients. All patients had intermediate (18) or high grade (one) NHL using the Working Formulation. The commonest histological subtype was diffuse large cell. Seventeen patients received postoperative therapy, comprising local radiotherapy in one and combination chemotherapy in the remaining 16. Eleven of the 19 patients remain disease-free 6-60 months from diagnosis. Because of the high incidence of bulky disease at this site, postoperative therapy may be indicated, even for patients with apparently completely excised stage I disease.

Full text

PDF
366

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage J. O., Dick F. R., Corder M. P., Garneau S. C., Platz C. E., Slymen D. J. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP). Cancer. 1982 Nov 1;50(9):1695–1702. doi: 10.1002/1097-0142(19821101)50:9<1695::aid-cncr2820500907>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Arseneau J. C., Canellos G. P., Banks P. M., Berard C. W., Gralnick H. R., DeVita V. T., Jr American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med. 1975 Mar;58(3):314–321. doi: 10.1016/0002-9343(75)90597-5. [DOI] [PubMed] [Google Scholar]
  3. Burgess J. N., Dockerty M. B., ReMine W. H. Sarcomatous lesions of the stomach. Ann Surg. 1971 May;173(5):758–766. doi: 10.1097/00000658-197105000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  5. Cooper B. T., Holmes G. K., Ferguson R., Cooke W. T. Celiac disease and malignancy. Medicine (Baltimore) 1980 Jul;59(4):249–261. doi: 10.1097/00005792-198007000-00002. [DOI] [PubMed] [Google Scholar]
  6. DAWSON I. M., CORNES J. S., MORSON B. C. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961 Jul;49:80–89. doi: 10.1002/bjs.18004921319. [DOI] [PubMed] [Google Scholar]
  7. Dragosics B., Bauer P., Radaszkiewicz T. Primary gastrointestinal non-Hodgkin's lymphomas. A retrospective clinicopathologic study of 150 cases. Cancer. 1985 Mar 1;55(5):1060–1073. doi: 10.1002/1097-0142(19850301)55:5<1060::aid-cncr2820550523>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  8. Fleming I. D., Mitchell S., Dilawari R. A. The role of surgery in the management of gastric lymphoma. Cancer. 1982 Mar 15;49(6):1135–1141. doi: 10.1002/1097-0142(19820315)49:6<1135::aid-cncr2820490612>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  9. Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  10. GOUGH K. R., READ A. E., NAISH J. M. Intestinal reticulosis as a complication of idiopathic steatorrhoea. Gut. 1962 Sep;3:232–239. doi: 10.1136/gut.3.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hande K. R., Fisher R. I., DeVita V. T., Chabner B. A., Young R. C. Diffuse histiocytic lymphoma involving the gastrointestinal tract. Cancer. 1978 May;41(5):1984–1989. doi: 10.1002/1097-0142(197805)41:5<1984::aid-cncr2820410544>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  12. Herrmann R., Panahon A. M., Barcos M. P., Walsh D., Stutzman L. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer. 1980 Jul 1;46(1):215–222. doi: 10.1002/1097-0142(19800701)46:1<215::aid-cncr2820460136>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  13. Krikorian J. G., Burke J. S., Rosenberg S. A., Kaplan H. S. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. N Engl J Med. 1979 Mar 1;300(9):452–458. doi: 10.1056/NEJM197903013000902. [DOI] [PubMed] [Google Scholar]
  14. Lewin K. J., Ranchod M., Dorfman R. F. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978 Aug;42(2):693–707. doi: 10.1002/1097-0142(197808)42:2<693::aid-cncr2820420241>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  15. Luce J. K., Gamble J. F., Wilson H. E., Monto R. W., Isaacs B. L., Palmer R. L., Coltman C. A., Jr, Hewlett J. S., Gehan E. A., Frei E., 3rd Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma. Cancer. 1971 Aug;28(2):306–317. doi: 10.1002/1097-0142(197108)28:2<306::aid-cncr2820280208>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  16. Mead G. M., Whitehouse J. M., Thompson J., Sweetenham J. W., Williams C. J., Wright D. H. Clinical features and management of malignant histiocytosis of the intestine. Cancer. 1987 Dec 1;60(11):2791–2796. doi: 10.1002/1097-0142(19871201)60:11<2791::aid-cncr2820601132>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  17. Sheahan D. G., Martin F., Baginsky S., Mallory G. K., Zamcheck N. Multiple lymphomatous polyposis of the gastrointestinal tract. Cancer. 1971 Aug;28(2):408–425. doi: 10.1002/1097-0142(197108)28:2<408::aid-cncr2820280222>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  18. Shepherd F. A., Evans W. K., Kutas G., Yau J. C., Dang P., Scott J. G., Farquharson H. A., Francombe W. H., Bailey D., Baker M. A. Chemotherapy following surgery for stages IE and IIE non-Hodgkin's lymphoma of the gastrointestinal tract. J Clin Oncol. 1988 Feb;6(2):253–260. doi: 10.1200/JCO.1988.6.2.253. [DOI] [PubMed] [Google Scholar]
  19. Starzl T. E., Nalesnik M. A., Porter K. A., Ho M., Iwatsuki S., Griffith B. P., Rosenthal J. T., Hakala T. R., Shaw B. W., Jr, Hardesty R. L. Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet. 1984 Mar 17;1(8377):583–587. doi: 10.1016/s0140-6736(84)90994-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Weingrad D. N., Decosse J. J., Sherlock P., Straus D., Lieberman P. H., Filippa D. A. Primary gastrointestinal lymphoma: a 30-year review. Cancer. 1982 Mar 15;49(6):1258–1265. doi: 10.1002/1097-0142(19820315)49:6<1258::aid-cncr2820490630>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES